Brevan Howard Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,305
Closed -$50.6K 1152
2023
Q4
$50.6K Buy
+1,305
New +$50.6K ﹤0.01% 946